Results 141 to 150 of about 21,523 (174)

Safety and Efficacy of Direct Oral Anticoagulants Versus Standard Therapy for Venous Thromboembolism in Cancer Patients: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials. [PDF]

J Clin Med
Shahbar A, Alshahrani S, Alhifany A, Alnuhait M, Noor A, Almutairi A, Alhamdan FA, Alshamrani AA, Hakami AY.   +8 more
europepmc   +1 more source

The comparison of inflammation markers in patients with non-valvular atrial fibrillation using warfarin and switched to apixaban. [PDF]

Pak J Med Sci
Duman OO, Alpaslan E.
europepmc   +1 more source

Anticoagulation Therapy in Advanced Chronic Kidney Disease: Balancing Bleeding and Thromboembolic Risk. [PDF]

Int J Mol Sci
Suliman IL, Tuta LA, Pana C, Panculescu FG, Alexandru A, Fasie D, Cimpineanu B, Popescu S, Enache FD, Nitu RA, Chisnoiu T, Popa MF, Tudor IC, Mihai ML, Deacu S, Cozaru GC, Bordeianu I.   +16 more
europepmc   +1 more source

Association between concomitant use of direct oral anticoagulants with antidepressants and an increased risk of hemorrhage: analysis of the food and drug administration adverse event reporting system database. [PDF]

Front Med (Lausanne)
Ran Y, Zhang Y, Cai Y, Liu H.
europepmc   +1 more source

Comparing Efficacy and Safety of Different Anticoagulants in Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis. [PDF]

Clin Appl Thromb Hemost
Waseem MH, Abideen ZU, Rissardo JP, Khan MH, Farhan K, Fornari Caprara AL, Thada PK, Dmytriw AA.   +7 more
europepmc   +1 more source

The Shocking Case of a Bleeding Heart. [PDF]

J Community Hosp Intern Med Perspect
Khan MI, Israr S, Khan MH, Jaafar N, Sharma R, Ahmed S.   +5 more
europepmc   +1 more source

Characterizing Apixaban Pharmacokinetics Through Physiologically-Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans. [PDF]

CPT Pharmacometrics Syst Pharmacol
Tsuchitani T, Kou W, Tomi M, Sugiyama Y.
europepmc   +1 more source

Safety Profile of Warfarin and Apixaban for Deep Vein Thrombosis in Patients With Chronic Kidney Disease. [PDF]

Cureus
Kausar F, Nadeem O, Khalil A, Ahmad S, Ali W.   +4 more
europepmc   +1 more source

Reduced versus standard dose apixaban for secondary prevention of cancer-associated venous thromboembolism: A systematic review and meta-analysis. [PDF]

Front Oncol
Malhotra V, Patel SG, Feinaj A, Amin D, Ash H, Boozo MB, Breslow Z, Trube J, Farooq MZ, Sabina M.   +9 more
europepmc   +1 more source

Bleeding prediction by rotational thromboelastometry in chronic hemodialysis patients with non-valvular atrial fibrillation on apixaban. [PDF]

World J Cardiol
Bacharaki D, Kyriakou E, Sardeli A, Nikolopoulos P, Triantaphyllis G, Drakou A, Makris F, Spanou E, Triantou E, Haviaras E, Fatourou A, Poulis A, Tsantes A, Kyriazis J, Lionaki S.   +14 more
europepmc   +1 more source